Brighton, MA, United States of America

Mengmeng Zheng

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of South Florida. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mengmeng Zheng. Retrieved from https://idiyas.com/inventor/mengmeng-zheng-6xdwfix8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mengmeng Zheng: Innovator in Cancer Treatment

Introduction

Mengmeng Zheng is a notable inventor based in Brighton, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of cyclic compounds.

Latest Patents

Mengmeng Zheng holds a patent for cyclic peptidomimetics that are designed to antagonize the extracellular domain of EGFR. This patent, which addresses critical methods for treating cancer, showcases her commitment to advancing medical science. She has 1 patent to her name.

Career Highlights

Currently, Mengmeng Zheng is affiliated with the University of South Florida, where she continues her research in the field of cancer therapeutics. Her work is characterized by a strong focus on developing novel compounds that can improve treatment outcomes for cancer patients.

Collaborations

One of her notable collaborators is Jianfeng Cai, who contributes to the research efforts in their shared field of study.

Conclusion

Mengmeng Zheng's innovative work in developing cyclic compounds for cancer treatment highlights her role as a key figure in medical research. Her contributions are paving the way for new therapeutic strategies in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…